COMMONS

Evidence taken into future of AstraZeneca

13 May 2014

On Tuesday 13 May the Business, Innovation and Skills Committee takes evidence on Pfizer's proposed takeover of AstraZeneca. The Committee will hear from trade unions, the Chairman and Chief Executive of Pfizer Inc., Chief Executive, AstraZeneca plc and the Secretary of State for Business, Innovation and Skills. 

Witnesses

Tuesday 13 May 2014; Grimond Room, Portcullis House 

At 9.30am:

  • Tony Burke, Assistant General Secretary, Unite
  • Allan Black, National Officer, GMB

At 10am:

  • Ian Read, Chairman and Chief Executive, Pfizer Inc.
  • Frank D'Amelio, Executive Vice President, Business Operations and Chief Financial Officer, Pfizer Inc.
  • Jonathan Emms, UK Managing Director, Pfizer Inc.

At 11.15am:

  • Pascal Soriot, Chief Executive Officer, AstraZeneca PLC
  • Mene Pangalos, Executive Vice president, Innovative Medicines and Early Development, AstraZeneca PLC
  • Dr Jane Osbourn, Vice President, R&D Medlmmune, Cambridge

At 1pm:

  • Rt Hon Dr Vince Cable MP, Secretary of State for Business, Innovation and Skills

Further information

Image: AstraZeneca

More news on: Parliament, government and politics, Central government, Business, industry and consumers, Parliament, Science and technology, Research and innovation, House of Commons news, Commons news, Committee news, Companies, Ministers

Share this page